All
Daily Aspirin Use Could Reduce Ovarian Cancer Risk and Improve Survival
October 14th 2018New research indicates that aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil) or naproxen (Aleve) could not only reduce the risk of ovarian cancer, but also improve survival with daily use.
Committee Supports FDA Approval of CT-P10 for Non-Hodgkin Lymphoma Treatment
October 10th 2018The Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee voted 16-0 in support of the agency granting approval to CT-P10, a biosimilar of Rituxan (rituximab), which is a drug used to treat non-Hodgkin lymphoma.
Immunotherapy's Role in Advanced Bladder Cancer Continues to Evolve
October 5th 2018Immunotherapy has been a buzzworthy topic in the field of bladder cancer over the last couple of years. However, according to a Food and Drug Administration (FDA) safety warning, patients with metastatic disease may need to have their treatment altered.
Aromatherapy and Reflexology Drastically Reduce Pain, Anxiety in Cervical Cancer Treatment
October 4th 2018Non-pharmacologic integrative medicine approaches such as aromatherapy and reflexology can dramatically reduce the pain and anxiety associated with cervical radiation therapy, according to a clinical study currently underway at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
Cancer Survivor Gives Back by Lending an Ear, Providing Comfort
October 3rd 2018For many cancer survivors, the thought of returning to their cancer clinic after treatment ends may be off-putting, as it could bring up difficult memories. But Arleen Weitz could not wait to get back into the infusion center at the Sidney Kimmel Cancer Center (SKCC), Jefferson Health to do some good.